Neil Sengupta to Liver Cirrhosis
This is a "connection" page, showing publications Neil Sengupta has written about Liver Cirrhosis.
Connection Strength
1.148
-
Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score. PLoS One. 2016; 11(2):e0147237.
Score: 0.464
-
Psychoactive Medications Increase the Risk of Falls and Fall-related Injuries in Hospitalized Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2015 Sep; 13(9):1670-5.
Score: 0.436
-
A risk score to predict the development of hepatic encephalopathy in a population-based cohort of patients with cirrhosis. Hepatology. 2018 10; 68(4):1498-1507.
Score: 0.135
-
Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration Controlled Transient Elastography. Am J Gastroenterol. 2015 Sep; 110(9):1298-304.
Score: 0.112